Stock 1952 EVEREST MEDICINES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Everest Medicines Limited

Equities

1952

KYG3224E1061

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:05 2024-05-31 am EDT 		5-day change 1st Jan Change
22.05 HKD +1.15% Intraday chart for Everest Medicines Limited -4.34% +5.50%
May. 14 Calliditas Therapeutics Partner Offers Nefecon in China; Shares Rise MT
May. 14 Everest Medicines Announces Commercial Launch and First Prescription for NEFECON in Mainland China CI

Analyst Reco.

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Everest Medicines and Gilead Sciences Jointly Announce Phase 2B Study of Sacituzumab Govitecan Conducted in China of Patients with Metastatic Triple-Negative Breast Cancer Meets Primary Overall Response Rate Endpoint
CI
EVEREST MEDICINES : Nomura Starts Everest Medicines at Buy With HK$110 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 1952 Stock
  4. News Everest Medicines Limited
  5. Analyst Reco.